The India advanced wound care management market is estimated to be valued at US$ 281.1 million in 2022 and is expected to exhibit a CAGR of 5.1% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Advanced wound care products are innovative wound healing products that help manage complex and chronic wounds related to leg ulcers, pressure ulcers, and surgical and traumatic wounds among others. These products prevent infections, manage excess fluid from the wound, and maintain a moist wound environment that promotes healing. The growing geriatric population suffering from diabetes and pressure ulcers has increased the need for advanced wound care products in India.
Market key trends:
The rising prevalence of diabetes is a major driver of growth in the Indian advanced wound care management market. As per the International Diabetes Federation (IDF), India has the second-highest number of diabetic patients in the world with approximately 77 million cases in 2019. Untreated diabetes leads to various complications including foot ulcers that require advanced treatment. Wounds related to diabetes accounted for over 40% of the total wound management expenditure in India in 2021. Advanced wound care products that help manage acute and chronic diabetic foot ulcers effectively are gaining increased adoption to reduce healthcare costs associated with amputations and hospitalizations.
Porter’s Analysis
Threat of new entrants: Low capital requirements and established brand recognition of existing players create significant barriers for new entrants.
Bargaining power of buyers: Relatively high number of product options provides buyers with bargaining power to demand competitive pricing.
Bargaining power of suppliers: Established supply networks of key players reduce suppliers’ ability to influence prices.
Threat of new substitutes: Alternate advanced wound care options pose threat of substitution.
Competitive rivalry: Intense competition among existing players.
SWOT Analysis
Strengths: Growing geriatric population prone to chronic wounds and emergence of advanced products boost market growth.
Weaknesses: High cost of advanced treatments limits widespread adoption. Lack of reimbursement policies in developing regions hampers market revenues.
Opportunities: Rising incidence of diabetes and associated complications widen opportunities. Growing awareness about available treatment alternatives fuels demand.
Threats: Limited healthcare spending and strong presence of conventional treatment methods restrict market growth.
Key Takeaways
The India advanced wound care management market is expected to witness high growth, exhibiting CAGR of 5.1% over the forecast period, due to increasing prevalence of chronic diseases such as diabetes. Rising cases of diabetes related foot ulcers and diabetic foot wounds in India propel market revenues.
Regionally, southern India dominates the market and is estimated to grow at the fastest rate during the analysis period owing to rising healthcare standards. Western India also offers lucrative opportunities due to presence of leading medical facilities in major cities.
Key players operating in the India Advanced Wound Care Management market are Smith and Nephew Plc, Coloplast A/S, Johnson and Johnson, 3M, Convatec Group Plc, Cologenesis Healthcare Pvt Ltd, Mil laboratories Pvt Ltd, Essity AB, Eucare Pharmaceuticals Ltd. Major players focus on bringing advanced product variants and expanding access to rural markets through new partnerships.
Read More:
